DI FRANCESCO, JACOPO COSIMO
 Distribuzione geografica
Continente #
NA - Nord America 5.416
EU - Europa 2.456
AS - Asia 999
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
OC - Oceania 4
Totale 8.916
Nazione #
US - Stati Uniti d'America 5.327
IT - Italia 571
DE - Germania 492
CN - Cina 367
SE - Svezia 344
SG - Singapore 339
IE - Irlanda 280
RU - Federazione Russa 219
GB - Regno Unito 159
UA - Ucraina 152
HK - Hong Kong 107
CA - Canada 83
VN - Vietnam 64
FI - Finlandia 63
FR - Francia 47
IN - India 43
BE - Belgio 31
DK - Danimarca 30
AT - Austria 29
TR - Turchia 27
JP - Giappone 14
CL - Cile 13
IR - Iran 12
NL - Olanda 11
ID - Indonesia 9
BR - Brasile 8
ES - Italia 7
EU - Europa 7
GE - Georgia 5
IQ - Iraq 5
DO - Repubblica Dominicana 4
PT - Portogallo 4
RO - Romania 4
AU - Australia 3
NG - Nigeria 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EC - Ecuador 2
GR - Grecia 2
HU - Ungheria 2
KR - Corea 2
MU - Mauritius 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EE - Estonia 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
UY - Uruguay 1
Totale 8.916
Città #
Ann Arbor 1.487
Chandler 410
Fairfield 392
Woodbridge 392
Frankfurt am Main 363
Wilmington 337
Singapore 295
Dublin 271
Ashburn 262
Houston 254
Milan 202
Jacksonville 174
Dearborn 160
Seattle 149
New York 137
Cambridge 132
Santa Clara 132
Princeton 113
Hong Kong 105
Nanjing 79
Shanghai 61
Lawrence 47
Altamura 38
Dong Ket 37
Lachine 30
Beijing 29
Helsinki 29
Vienna 28
Boardman 26
Brussels 24
Andover 22
Grafing 21
Ottawa 21
San Diego 20
Nanchang 19
Pune 19
Fremont 18
Jinan 18
Monza 18
Guangzhou 17
Rome 17
Shenyang 15
Zhengzhou 15
Kocaeli 14
Los Angeles 14
Toronto 14
Santiago 13
Changsha 12
Falls Church 12
London 12
Tianjin 12
Hebei 11
Hangzhou 10
Lissone 10
Moscow 10
Edmonton 9
Jakarta 9
Leawood 9
Monmouth Junction 9
Jiaxing 8
Mountain View 8
Bari 7
Dallas 7
Detroit 7
Kunming 7
Turin 7
Chicago 6
Segrate 6
Taizhou 6
Auburn Hills 5
Brugherio 5
Dalmine 5
Hefei 5
Munich 5
Ningbo 5
University Park 5
Bologna 4
Brooklyn 4
Lappeenranta 4
Leipzig 4
Norwalk 4
Peschiera Borromeo 4
Rho 4
Samaná 4
Sesto San Giovanni 4
Southwark 4
Squillace 4
Stockholm 4
São Paulo 4
Tokyo 4
Truyes 4
Verona 4
Abuja 3
Alpharetta 3
Bergamo 3
Bonndorf 3
Borgo Val di Taro 3
Bournemouth 3
Brescia 3
Casarile 3
Totale 6.807
Nome #
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 372
Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer's disease and cerebral amyloid angiopathy 334
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 310
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 280
Clinical, biological and neuroradiological evolution of Cerebral Amyloid Angiopathy-related inflammation: the iCAβ International Network longitudinal study. 276
Effect of the ketogenic diet in excitable tissues 247
Generation and validation of algorithms to identify subjects with dementia using administrative data 245
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 239
Progressive epileptic encephalopathy associated with a novel HCN2 mutation 223
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 204
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 198
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 193
Cardiac and neuronal HCN channelopathies 190
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 189
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 188
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 187
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 186
Prodromal Alzheimer's Disease Presenting as Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Amyloid-Related Imaging Abnormalities and High Cerebrospinal Fluid Anti-Aβ Autoantibodies 184
Brain targets: can you believe your own eyes? 176
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 176
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 172
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 166
Screening of SLC2A1 in a large cohort of patients suspected for Glut1 deficiency syndrome: identification of novel variants and associated phenotypes 164
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-A beta auto-antibodies 162
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related Inflammation 160
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 159
Cerebral amyloid angiopathy-related inflammation: an emerging disease 156
A case of Leber hereditary optic neuropathy plus dystonia caused by G14459A mitochondrial mutation 156
Do the functional properties of HCN1 mutants correlate with the clinical features in epileptic patients? 155
Autoimmune encephalopathy in Graves' disease: Remission after total thyroidectomy 153
HCN1 novel mutations in familiar generalized epilepsy 150
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 148
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 147
Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network 144
Adult-Onset Epilepsy in Presymptomatic Alzheimer's Disease: A Retrospective Study 142
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 141
Epilptic seizures and psychogenic non-epileptic seizures 137
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 137
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 128
HCN1 mutation spectrum: From neonatal epileptic encephalopathy to benign generalized epilepsy and beyond 127
MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines 125
Complicanze neurologiche di malattie internistiche 123
Anti-Aß autoantibodies in cerebral amyloid angiopathy-related inflammation: a human spontaneous model of amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease 122
Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management 121
Immune-mediated mechanisms in the pathogenesis of cerebral amyloid angiopathy-related inflammation and Alzheimer's disease: Role of anti-Aβ auto-antibodie 110
Recessive loss-of-function mutation in the pacemaker HCN2 channel causing increased neuronal excitability in a patient with idiopathic generalized epilepsy 107
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 106
LATE-ONSET EPILEPSY WITH UNKNOWN ETIOLOGY: A PILOT STUDY ON NEUROPSYCHOLOGICAL PROFILE, CEREBROSPINAL FLUID BIOMARKERS, AND QUANTITATIVE EEG CHARACTERISTICS 92
Anti-AB autoantibodies and endothelial damage during amyloid-related imaging abnormalities (ARIA): report from the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's disease Biomarkers Collaborative Network 88
Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project 88
Neurological soft signs are increased in migraine without aura: relationship with the affective status 82
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 73
Association of Microglial Activation With Spontaneous ARIA-E and Cerebrospinal Fluid Levels of Anti-Aβ Autoantibodies 72
Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 70
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 69
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 66
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 62
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet 59
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 54
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 51
Cerebral Amyloid Angiopathy-Related Inflammation 51
Epilepsy in Cerebral Amyloid Angiopathy: an observational retrospective study of a large population 49
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 21
Totale 9.462
Categoria #
all - tutte 31.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.451


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.068 0 0 0 0 131 187 222 105 149 121 117 36
2020/20211.643 75 88 181 161 121 140 147 174 147 151 109 149
2021/20221.015 119 111 115 84 84 94 34 46 50 48 78 152
2022/20231.695 162 472 158 188 124 237 34 82 167 11 25 35
2023/20241.056 27 62 49 69 152 257 162 56 78 11 17 116
2024/2025867 135 283 156 97 196 0 0 0 0 0 0 0
Totale 9.462